New blood test aims to track stomach and colon cancer spread
NCT ID NCT04929015
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This study is creating a personalized blood test for people with gastrointestinal cancers that have spread to the lining of the abdomen. Researchers collect tumor tissue and blood samples to design a test that detects cancer DNA in the blood. The goal is to see if this test can help monitor cancer over time and guide treatment decisions. About 30 participants will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL CARCINOMATOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
RWJBarnabas Health - Cooperman Barnabas, Livingston
Livingston, New Jersey, 07039, United States
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
Conditions
Explore the condition pages connected to this study.